Search
STAAR Surgical Co
STAAAdd to Watchlist
22.150USD
-0.420-1.86%
Close 10-06 16:00（ET）
1.10BMarket Cap
LossP/E TTM
STAAR Surgical Co (STAA) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to STAAR Surgical Co in the past month.
Hold
1 Strong Buy
2 Buy
8 Hold
0 Sell
0 Strong Sell
Target Price
28.000USD+24.61%
STAA Analyst Recommendation Trends
In the current month, STAA has received 2 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. STAA average Analyst price target in the last month is 28.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
0
0
0
0
0
0
2
2
2
1
0
0
0
0
8
8
9
10
10
9
9
9
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
11
11
11
11
11
10
9
9
STAA Analyst Rating for Peer Comparison
Updated: Oct 6, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
12
13
5
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Medtronic PLC
MDT
8
11
10
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, STAA EPS is projected to reach 0.052 in FY2026Q3, following reported EPS of 0.160 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.06
-0.06
0.16
0.05
-0.04
Actual
-0.37
0.10
0.16
--
--
Surprise
-743.75%
+263.62%
+0.65%
--
--
FAQs
What is STAAR Surgical Co's expected revenue for the next quarter?
STAAR Surgical Co's expected revenue is 78.76M.
What is STAAR Surgical Co's price target?
Analysts forecast that STAAR Surgical Co's price target is USD 28.00, with the highest forecast at USD 37.00 and the lowest forecast at USD 19.00.
How have STAAR Surgical CoSTAA's recent earnings per share performed?
The market expectation was USD 0.16, while STAAR Surgical CoSTAA's earnings per share (EPS) for the previous quarter was USD 0.10. EPS for the next quarter is expected at USD 0.05.
What is the analyst rating for STAAR Surgical Co?
Based on the ratings of STAAR Surgical Co's stock from 11 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.